The intent desk · /best/ cluster hub
The /best/ files: eight buying intents, each answered with audited math
“Best” depends on the sentence you'd finish it with — best flat-rate, best at maintenance, best without insurance — so this cluster answers eight specific intents instead of one vague crown, every file built on the same audited dataset: the $139/$119 dose-proof anchors, the conditional ~$133 prepay, the $249 freedom premium, the $199–$299 tiers, the $349+ brand rungs, all dated, all challengeable. Pick the sentence you're actually asking.
Best flat-rate tirzepatide
One price that ignores your dose — the fork worth ~$1,000/year.
Best tirzepatide, no hidden fees
The four fee families, audited to zero — and the ten-minute replication.
Best for maintenance doses
Priced where you'll live — with the switch math for tier-payers.
Best for higher doses (12.5–15 mg)
Where dose-scaling bites hardest and dose-proofing pays most.
Cheapest starter price
Month-one podium vs the twelve-month inversion — and the honest starter.
Best cash-pay tirzepatide
The no-insurance lane end to end, plus the HSA/FSA multiplier.
Best flat-rate semaglutide
The $119 line that doesn't move across a near-tenfold climb.
Best semaglutide without insurance
The $119 floor, the $380 brand gap, and the check to run first.
The flagships behind every file: the cost index · the under-$150 club · the tirzepatide ladder · value per point · the budget lanes · the open dataset. Compounded products are not FDA-approved; trial certificates belong to the brands; every number above carries its verification tier and date.